By means of differential display reverse-transcriptase polymerase chain reaction, increased expression of the mRNA encoding the anti-apoptosis gene IEX-1L was found in respiratory epithelial cells infected with respiratory syncytial virus (RSV). IEX-1L mRNA expression increased 5-7-fold in RSV-infected cells at 72 h after infection but remained unchanged in cells exposed to irradiated, replication-incompetent RSV. Because IEX-1L is reported to protect cells from apoptosis induced by tumor necrosis factor (TNF)-a, the effect of TNF-a on epithelial cell apoptosis in the context of RSV infection was determined. Epithelial cells were exposed to vehicle, RSV, or irradiated RSV for 72 h, and then TNF-a was added to appropriate cultures. Cytochemical staining of cellular DNA with 4,6-diamidino-2-phenylindole demonstrated TNF-a-induced apoptosis in 23.4% of control cells but only 5% of RSV-infected cells. These data show that RSV infection protects epithelial cells from TNF-a-induced apoptosis and that this effect is temporally associated with IEX-1L gene expression.
Although the cellular immune response to respiratory syncytial virus (RSV) infection has been studied extensively, the interactions between RSV and its primary target, the respiratory epithelial cell, are just beginning to be understood. Further characterization of the interactions between RSV and respiratory epithelial cells is necessary to advance our understanding of the host mucosal immune response to this infection. To identify and characterize genes that undergo alteration in expression in response to RSV infection, we embarked on a systematic comparison of the mRNA species expressed by infected and uninfected respiratory epithelial cells by means of the semiquantitative technique based on reverse-transcriptase (RT) polymerase chain reaction (PCR) and known as differential display [1, 2] . Using this approach, we investigated the effect of RSV-infected epithelial cells on expression of the mRNA encoding the anti-apoptosis gene IEX-1L and the association of expression of this gene in the context of RSV infection with protection from apoptosis induced by tumor necrosis factor (TNF)-a.
Materials and Methods
Cell culture. The HEp-2 (human laryngeal carcinoma) cell line was obtained from American Type Culture Collection (ATCC, Rockville, MD) and cultured in RPMI (Life Technologies GIBCO BRL, Gaithersburg, MD) supplemented with 10% fetal bovine serum (FBS), 2 mM glutamine, and penicillin-streptomycin (Life Technologies) (complete RPMI) at 37ЊC in 5% CO 2 .
Preparation of stock virus suspensions. RSV-B (ATCC VR-1401), RSV-A2 (ATCC VR-1400), and adenovirus type 21 (ATCC VR-1099) were obtained from ATCC. The ATCC isolates of RSV and adenovirus were used to inoculate 180-cm 2 flasks containing semiconfluent monolayers of HEp-2 cells cultured as described above. When cytopathic effect reached ∼80%, the culture supernatants were harvested, and cellular debris was removed by centrifugation at 500 g. Aliquots of the RSV suspension were flash frozen and stored at Ϫ80ЊC. Infectivity, determined by quantitative shell vial assay [3] , was pfu/mL. A control suspension 6 2-5 ϫ 10 was prepared from uninfected HEp-2 cell cultures in an otherwise identical fashion.
Exposure of HEp-2 cells to vehicle, RSV, adenovirus, or irradiated RSV. Semiconfluent HEp-2 cell monolayers ( cells in 30 6 9 ϫ 10 mL of complete media, or cells/mL) were exposed to 1 mL 5 3 ϫ 10 of control suspension (vehicle), inoculated with 1 mL of RSV-B or adenovirus type 21 suspension (MOI, ∼0.5), or exposed to 1 mL of irradiated RSV suspension prepared as described elsewhere [4] . Infection of appropriate monolayers was confirmed by direct fluorescent antibody staining as described elsewhere [3] . No cytopathic effect was observed in control tissue cultures or cultures inoculated with vehicle or irradiated RSV suspension. Likewise, virus-specific direct fluorescent antibody staining of controls was negative.
RNA isolation and Northern blot analysis. Total cellular RNA was extracted from HEp-2 cells at several time points after exposure to vehicle, RSV, adenovirus, or inactivated RSV (Rnazol; Teltest, Friendswood, TX). For Northern blot analysis, 15 mg of RNA per lane was separated on 1.2% agarose formaldehyde gels [5] and blotted onto nylon membranes. Adenoid-derived epithelial cells were prepared in the same manner with 8 mg of RNA per lane. After overnight hybridization with radiolabeled probes, Northern blots were washed twice at 55ЊC in 0.2ϫ sodium-sodium phosphate-EDTA and 0.1% SDS and were then exposed to film. Where indicated, signal-to-actin optical density ratios were determined by means of an imaging densitometer (GS-670; Bio-Rad Laboratories, Hercules, CA).
Differential display PCR. Differential display was done as previously described [6, 7] . In brief, 0.3 mg of total RNA, isolated from HEp-2 cells after infection with RSV at several time points, was reverse transcribed with specific anchored oligo-dT11XY primers (Display Systems Biotech, Vista, CA). PCR was done by use of the same anchoring primer and 1 of the 24 random upstream 10-bp primers supplied in the kit. Amplification was for 40 cycles with denaturation at 94ЊC for 30 s, annealing at 40ЊC for 1 min, and elongation at 72ЊC for 1 min with a 10-min extension at 72ЊC after the last cycle. A trace amount of 35 S-labeled dATP (Amersham Pharmacia Biotech, Piscataway, NJ) was included in the PCR master mix, according to the manufacturer's protocols. Amplified fragments from the 5 cDNA fractions (days 0-4 after infection) were separated on a 6% denaturing polyacrylamide gel, transferred, dried on Whatman paper (3M, St. Paul, MN), and exposed to film for 10 days. Bands that appeared to be differentially expressed were cut from the gel and eluted into 100 mL of water by boiling for 10 min. The eluted DNA samples were then used as templates for PCR amplification: 2.5-12.5 mL of the eluted product was used in a 50-mL PCR reaction containing 5 mL of 10ϫ PCR buffer (Boehringer Mannheim, Indianapolis), 5 mL of 500 mM dNTPs (Boehringer Mannheim), 2 mL of 25 mM downstream primer, 25 mL of 2 mM upstream primer (Display Systems), and 0.5 mL of Taq polymerase (Boehringer Mannheim). Cycling conditions were identical to the parameters used above. Reamplified products were electrophoresed on a 2% agarose gel, stained with ethidium bromide, cut, and gel purified (GeneClean II; Bio 101, Vista, CA). Differentially expressed fragments were labeled with random primers (Boehringer Mannheim) and used as probes for Northern blot analysis.
Cloning and sequencing of differentially expressed cDNAs. Differentially expressed cDNA amplicons, confirmed by Northern blot analysis, were subcloned into the pCR 2.1 vector (Invitrogen, Carlsbad, CA). Clones were confirmed once again by Northern blot analysis and sequenced by dideoxy sequencing (Amersham Pharmacia Biotech).
RT-PCR of the IEX-1L coding sequence. Total cellular RNA was harvested from HEp-2 cells on day 3 after RSV infection. Two micrograms of RNA was used in a cDNA synthesis reaction with oligo-dT16 and random hexamer primers (Boehringer Mannheim). Five microliters of this cDNA reaction mix was used in a 50-mL PCR containing IEX-1L gene-specific primers (20 mM each; GenBank accession no. AF071596; 5 -CACCATGTGTCACTC-TCGCAG and 3 -TTAGAAGGCGGCCGGGTGTTG), 5 mL of 10ϫ PCR buffer with 15 mM MgCl 2 , 5 mL of 5 mM dNTPs, and 2.5 IU of Taq polymerase. The 611-bp amplified full-length IEX-1L cDNA was subcloned into the pCR 2.1 vector and sequenced by use of vector-specific primers available from the manufacturer. The full-length coding sequence was obtained from the plasmid by restriction digestion (EcoRI; New England Biolabs, Beverly, MA), gel purified, and radiolabeled for use as a probe for Northern blot analysis.
Separation and culture of adenoid-derived epithelial cells. Adenoid tissue, removed at surgery, was immediately immersed in Lugol's solution and then washed extensively in PBS supplemented with antibiotics. The tissue was then incubated in Ham's F12 media containing 0.1% protease (Sigma, St. Louis) for 16 h with gentle agitation to dissociate the cells. After incubation, heat-inactivated FBS was added to 15% (vol/vol) of the mixture to inactivate the protease, and the tissue was filtered through a 60-mm nylon mesh. The cells were washed twice in PBS with 0.5% bovine serum albumin and 1 mM EDTA (PBE) and then counted. Each set of cells was resuspended in 50 mL PBE and 50 mL anti-CD45- 7 5 ϫ 10 conjugated magnetic beads (Miltenyi Biotec, Auburn, CA). Epithelial cells were negatively selected by magnetic-activated cell sorting according to the manufacturer's instructions. The epithelial cells were then cultured according to the method of Saito et al. [8] . After 2 washes in prewarmed media, the cells were resuspended in hormonally defined Ham's F12 media (20% FBS, 2 mM glutamine, 5 mg/mL insulin, 5 mg/mL transferrin, 25 mg/mL epidermal growth factor, 15 mg/mL endothelial cell growth supplement [Life Technologies], 6.5 ng/mL tri-iodothyronine, and 0.5 mg/mL hydrocortisone [Sigma]) at a concentration of cells/mL and seeded 4 5 ϫ 10 onto collagen-coated 24-well plates. Cells were incubated at 37ЊC in 5% CO 2 , and the medium was changed every 48 h. All epithelial cells used for subsequent experiments were passaged once and found to be free of adenovirus contamination by direct fluorescent antibody staining [3] .
Characterization of cultured epithelial cells. Under phase microscopy, beating cilia were seen on the surfaces of adenoidal epithelial cells. To determine the degree of nonepithelial cell contamination, smears of trypsinized cells were fixed in acetone, blocked with 10% nonimmune goat serum, stained with anti-cytokeratin (1 : 50) or anti-vimentin monoclonal antibody (1 : 20) (Chemicon, Temecula, CA) for 1 h and then with fluorescein isothiocyanate-conjugated goat anti-mouse antibody (1 : 25; Sigma) for 1 h at 37ЊC, and examined by use of fluorescence microscopy. Only those adenoid-derived cultures in which 190% of the cells stained positively with anti-cytokeratin antibody were used for further experiments. The 3T3 fibroblast cell line and HEp-2 epithelial cell line were used as controls for stain specificity (anticytokeratin is specific to epithelial cells; vimentin is specific to fibroblasts).
TNF-a induction of apoptosis in primary adenoid-derived epithelial cells. Cell monolayers ( cells) were exposed to equal 5 ∼ 5 ϫ 10 volumes of vehicle, RSV (MOI, ∼0.5), or irradiated RSV for 72 h. After a 6-h incubation in the presence of TNF-a (60 ng/mL), cells were washed in PBS, fixed in 1% formaldehyde for 15 min, postfixed in 70% ethanol for 15 min, and stained with 1 mg/mL 4,6-diamidino-2-phenylindole (DAPI) in PBS for 5 min. The pattern of nuclear DAPI staining was then examined by use of fluorescence microscopy. Estimates of apoptosis induced by TNF-a were determined for each condition by comparing the number of apoptotic cells demonstrating the characteristic nuclear staining of chromatin condensation to the total number of cells counted in 8 high-power fields (118-241 cells). All experiments were performed in triplicate.
Heterologous expression of IEX-IL in respiratory epithelial cells. The full-length coding sequence of IEX-1L was subcloned into the eukaryotic expression vector pCEp4 (Invitrogen), which contains a hygromycin-resistance cassette. By use of a 4-mm-gap cuvette, 10 7 HEp-2 cells were electroporated in the presence of 40 mg of either the pCEp4-IEX-1L construct or the pCEp4 vector alone (250 V, 1000 mF). After electroporation, cells were transferred to 100-cm 3 dishes containing 10 mL of complete RPMI, incubated for 48 h, and placed under hygromycin (2000 IU/mL) selection for 3, 7, or 16 days. At each time point, cells were divided. RNA was extracted from one set to confirm IEX-1L expression. The other set was split and incubated in the absence or presence of TNF-a (60 ng/mL), followed by staining with DAPI. Estimates of apoptosis induced by TNF-a were determined as described. All experiments were performed in triplicate.
Statistical analysis. x 2 tests were used to compare discrete data. Statistical significance was set at . P ! .05
Results

Differentially expressed mRNAs in HEp-2 cells in the absence or presence of RSV infection.
To identify mRNAs that are induced or repressed following RSV-B infection of HEp-2 cells, differential display was performed with total RNA isolated from these cells at times 0, 1, 2, 3, and 4 days after infection. fold increase in IEX-1L expression at 72 and 96 h after infection (lanes 9 and 10).
Irradiated RSV and adenovirus fail to induce IEX-1L expression.
Radiolabeled IEX-1L cDNA was used to probe Northern blots generated with RNA extracted from irradiated RSV-exposed HEp-2 cells (figure 2, middle) and adenovirus type 21-infected HEp-2 cells (figure 2, bottom) at times 0, 1, 2, 3, and 4 days. Under these conditions, normalization of the IEX-1L signal-to-actin ratio failed to demonstrate an increase in IEX-1L expression over time. 
IEX-1L expression increases 7-fold at 72 h after RSV infection in primary adenoidal epithelial cells.
RSV infection protects primary respiratory epithelial cells from apoptosis induced by TNF-a.
Representative fields of DAPIstained adenoid-derived epithelial cells exposed to 60 ng/mL TNF-a for 6 h in the absence and presence of RSV infection are shown in figure 4 . Unlike RSV-B-infected cells, uninfected epithelial cells and cells exposed to irradiated RSV demonstrate the characteristic nuclear staining of apoptosis (chromatin condensation) after exposure to TNF-a. The quantity of cells with chromatin condensation was expressed as the percentage of the total number of cells in 8 randomly selected high-power fields. Results from 3 independent experiments are shown in table 1. Exposure to TNF-a increased the percentage of apoptotic cells present after exposure to vehicle or irradiated RSV ( ) P ! .001 but failed to increase apoptosis over baseline levels in cells that were infected with RSV-B ( ). P = .5204 Heterologous IEX-1L expression protects epithelial cells from apoptosis induced by TNF-a. 
Discussion
Our results show that respiratory epithelial cells respond to RSV infection with increased expression of the anti-apoptosis gene IEX-1L and that expression of this gene is associated with protection from apoptosis induced by TNF-a. Up-regulation of the IEX-1L gene requires ongoing RSV replication, because irradiated, replication-incompetent RSV fails to induce its expression. Moreover, expression of IEX-1L does not increase over baseline during adenovirus infection, suggesting that induction of this gene is not a universal response to viral infection.
IEX-1L, which was originally cloned (by differential display) as a radiation-inducible early-response gene [9] , has only recently been recognized as an apoptosis inhibitor involved in NF-kB-mediated cell survival [10] . Interestingly, epithelial cells infected with RSV in tissue culture do not show features typical of apoptosis (e.g., membrane blebbing, fragmentation of chromosomal DNA into nucleosomal oligomers, and characteristic changes in the morphology of cell nuclei). Takeuchi et al. [11] have shown that RSV-infected cells up-regulate the expression of apoptosis-associated genes, including interferon regulatory factor 1, interleukin-1b-converting enzyme, and caspase-3, but do not undergo apoptosis. Up-regulation of IEX-1L during RSV infection may help to explain why RSV-infected epithelial cells are apparently protected from apoptosis.
Apoptosis is considered to be a highly efficient defense mechanism against invading viruses, allowing the infected host to dispose of viral proteins and nucleic acids without inducing an inflammatory response. It is therefore not surprising that some viruses have elaborate strategies to evade apoptotic destruction. DNA viruses, in particular those with large viral genomes, such as herpesviruses, poxviruses, and insect baculoviruses, encode several regulators of apoptosis [12] [13] [14] [15] . These DNA viruses have evolved strategies to inactivate p53, thereby preventing apoptosis triggered by p53 activation. More recently, it has become clear that these and other DNA viruses use various mechanisms, both dependent and independent of p53 inactivation, to block apoptosis. For example, the myxomavirus-encoded TNF-receptor homologue, M-T2, functions as a secreted glycoprotein that blocks the activity of TNF-a and also functions as an intracellular effector that inhibits apoptosis in myxomavirus-infected cells [16] . HEp-2 cells transfected with a plasmid encoding the human immunodeficiency virus type 1 Vpr gene [17] are protected from apoptosis. HEp-2 cells infected with herpes simplex virus type 1 fail to undergo apoptosis [18] , probably because of a virus-encoded anti-apoptosis gene. Conversely, we show evidence that RSV, an RNA virus with a small (∼15.2-kb) viral genome, may induce apoptosis, not by encoding an anti-apoptosis gene but by altering host cell expression of the apoptosis inhibitor IEX-1L. No published evidence suggests that any of the RSV-encoded proteins mimic host antiapoptosis proteins or directly alter the host apoptosis response. Although the 11 RSV proteins do not share homology with any known human proteins involved in apoptotic signaling, they may participate in the trans activation of the IEX-1L gene (either directly or indirectly), because active RSV replication is required for IEX-1L gene up-regulation. Of interest, Krilov et al. [19] and Pontrelli et al. [20] have shown that RSV-infected peripheral blood mononuclear cells and monocytes isolated from cord blood and from adults are protected from apoptosis when infected with RSV. The mechanism of protection in this context is unknown.
At first glance, virus-induced anti-apoptosis mechanisms appear advantageous only to the virus, whose replication and survival are dependent on host cell viability; however, RSVinfected epithelial cells are recognized as a major source of leukocyte chemoattractants [4, 8, [21] [22] [23] [24] [25] . Leukocyte recruitment to infected lung epithelium is necessary for clearance of virus [26] , and RSV-infected cells protected from apoptosis may continue to elaborate proinflammatory chemokines, thereby facilitating the host defense response to RSV. Under such conditions, persistent, efficient production of proinflammatory cytokines would allow continued recruitment of cytotoxic, viricidal leukocytes. Future studies will define the role that IEX-1L plays in the immunopathogenesis of RSV disease. These efforts will lead to a larger understanding of some of the initial cellular responses involved in the immunopathologic cascade of events experienced by patients with severe RSV infection.
